First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and 4-1BB, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from ...
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial This open-label phase II study ...
Forbes contributors publish independent expert analyses and insights. I write about relationships, personality, and everyday psychology. The initial months of a relationship, often referred to as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results